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Recently, software has become available to automate localization of phosphorylation sites from CID
data and to assign associated confidence scores. We present an algorithm, SLoMo (Site Localization
of Modifications), which extends this capability to ETD/ECD mass spectra. Furthermore, SLoMo caters
for both high and low resolution data and allows for site-localization of any UniMod post-translational
modification. SLoMo accepts input data from a variety of formats (e.g., Sequest, OMSSA). We validate
SLoMo with high and low resolution ETD, ECD, and CID data.
Keywords: phosphorylation • phosphopeptide • phosphoproteomics • site localization • Ascore • mass
spectrometry • post-translational modifications • bioinformatics
Introduction
Large-scale mass spectrometric identification of phospho-
peptides and phosphoproteins, termed phosphoproteomics,
has now become routine.1-5 Until recently these analyses relied
heavily on manual validation to confirm correct site localiza-
tion.6 This approach is both time-consuming and labor inten-
sive, making it impractical for large data sets. To reduce the
requirement for manual analysis, algorithms have been devel-
oped to automate site localization.6-9 These approaches use
statistical models for assessing site localization, and can be used
for computational analysis of large data sets in a short period
of time. The algorithm takes the peptide sequence identified
from a database search, compiles a list of all possible phos-
phorylation sites (or combinations of sites), and from this
generates a list of predicted ions. These ions are then matched
against the mass spectra from which the peptide was initially
identified in order to identify the number of matched ions, and
in particular the number of site-determining ions. Site-
determining ions are those ions which are unique for a
particular modification site/combination of modification sites.
While these algorithms represent a major step forward in
the development of tools to analyze large scale experimental
data sets generated from LC-MS/MS, to date their usage is
limited to peptides fragmented by collision-induced dissocia-
tion (CID). Recently, the radical-driven fragmentation tech-
niques electron transfer dissociation (ETD)10 and electron
capture dissociation (ECD)11 have been applied to the large-
scale analysis of phosphorylation.4,5,12 These techniques are
particularly well-suited to the analysis of phosphopeptides, as
the labile phosphate moiety is retained on peptide backbone
fragments, in contrast to fragmentation by CID in which loss
of the modification is the dominant pathway.13 An additional
limitation of the existing algorithms is that they accept peptide
identification output only from specific search engines, for
example, Sequest for Ascore and Mascot for MSQuant-
incorporated localization.6,7
To address these limitations, we sought to generate a new
site localization tool, based on the Ascore algorithm, but
capable of addressing a wider range of problems. In particular
our aims were to generate a tool which: (i) allows analysis of
data obtained using both CID and ETD/ECD fragmentation
methods; (ii) caters for both high and low resolution fragmen-
tation data; (iii) enables data to be read into the tool from a
variety of formats, using an extensible scheme; (iv) allows
analysis to be performed for a variety of modification types.
Our algorithm, SLoMo (Site Localization of Modifications),
allows calculation of hypothetical ions based on either CID or
ETD/ECD. SLoMo accepts the generic pepXML input format14
and incorporates options for searching for any modification
found in the UniMod database.6,15 Finally, we incorporate a
common database back-end allowing easy access to the source
data for advanced users, and increased speed for searches on
preproduced databases. We validate SLoMo by comparing it
to Ascore (for CID data, where both algorithms will produce
results), through the use of synthetic phosphopeptide libraries
and by manual validation of SLoMo localizations from in vivo
phosphorylated proteins. We demonstrate that SLoMo can
successfully localize phosphorylation sites from low resolution
ETD and CID data, and from high resolution ETD and ECD
data. The application of SLoMo to other modifications is
illustrated by localization of sites of methionine oxidation.
Finally, SLoMo analysis of OMSSA output (phosphorylation)
and Sequest output (oxidation) is shown.
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Experimental Section
Spectrum Preprocessing. Given an MS/MS spectrum gener-
ated for a peptide of precursor mass m, and a charge z, the
mass spectrum is preprocessed to remove peaks corresponding
to intact precursor ions and charge-reduced products (in ETD/
ECD mass spectra) and selected neutral losses (in CID mass
spectra) prior to binning the spectrum into 100 m/z windows.
SLoMo incorporates a tolerance t for region removal and
utilizes the general ppm error value e (also used in the
generated ion-to-mass spectrum matching part of the algo-
rithm) such that for ECD/ETD data peaks within the region R
are removed for:
m + Hi - e
i
e R e
m + Hi + t
i
+ e
i
where i is the charge state of the reduced precursor ion, (1 e
i e z), and H is the mass of a proton.
For CID data, peaks within region R are removed for:
m + Hz - e - n
z
e R e
m + Hz + e + t
z
- n
z
where n is the mass of the neutral loss entity, for example, n )
97.977 Da (H3PO4) for phosphopeptides. Potential neutral losses
are obtained by looking up data on the modification being
analyzed in UniMod. Each neutral loss is considered alone or
with additional neutral loss of water, and the region corre-
sponding to the neutral loss of water alone is also removed.
Ion List Generation/Filtering. Where ions are to be matched
against mass spectra generated from ECD/ETD events, c and
z ions N-terminal to a proline residue are not generated. (N-
terminal proline c and z ions are rarely observed in ECD/ETD
mass spectra16). Where there are multiple modifications of
different types (e.g., phosphorylation and acetylation) on a
single peptide only one type of modification will be used to
generate combinations of modification sites: all other modifi-
cations are considered to be correctly localized by the search
engine used to generate the peptide identifications, and remain
fixed.
Modification Matching. Modifications are mapped to Uni-
Mod records by matching modification information stored
within the pepXML file to the UniMod database. Matches are
made based on the amino acid identified as modified by the
initial protein database search and the mass difference of the
assigned modification. Specifically, the modification mass must
be within 10-4 Daltons of the modification mass recorded in
UniMod, and the amino acid must be specified in UniMod as
a site capable of having the modification present. For output
from the OMSSA database search algorithm,17 where conver-
sion to pepXML is currently unavailable, a user editable list is
provided which links the name given to the modification by
OMSSA (e.g., phosphorylation) to the UniMod ID number for
that modification (in the case of phosphorylation: 21).
Statistical Calculation. Ascore uses a cumulative binomial
probability model to calculate peptide and final Ascores:
P ) ∑
k)n
N (Nk )pk(1 - p)N-k
where N is the number of trials (in this case the number of
potential ions generated by the peptide under examination),
n is the number of successes (the number of times an ion was
matched to a peak in the mass spectrum), and p is the
probability of a random match between an ion and a peak.
Ascore uses a tolerance of (0.5 m/z for matching a peak to an
ion. This means that for a given peak depth of n peaks per 100
m/z window the probability of a match by chance is:
p ) n
100
However, in SLoMo, the tolerance is expressed in parts per
million rather than inm/z units. Thus the probability becomes:
p )
xmin + xmax
2
×
2e
1000000
×
n
100
where xmin is the value (m/z) of the lowest m/z peak in the
mass spectrum, xmax is the value (m/z) of the highest m/z peak
in the mass spectrum, and e is the tolerance in parts per
million.
In order to overcome computational issues associated with
calculating the binomial probability for large number of trial
events (which can lead to overflow and/or underflow issues
during calculation), SLoMo utilizes a cumulative Poisson
distribution when the number of trial events is such that tests
for underflow and overflow issues in the binomial calculation
are true. When this is the case, the following equation is used
to calculate the probability score:
P ) ∑
k)n
N
e λλk
k!
where λ ) np.
Test Datasets. 1. Ascore Data Set. A test data set of 135
phosphoserine containing peptides was downloaded from
http://ascore.med.harvard.edu/examples/sp.zip to test against
SLoMo and Ascore (run online at http://ascore.med.harvard-
.edu/ascore.php.
2. Synthetic Phosphopeptide Libraries. Synthetic phospho-
peptide libraries were synthesized by Alta Biosciences (Bir-
mingham, UK). The libraries were based on the peptide
sequences: GPSGxVpSxAQLx[K/R] and SxPFKxpSPLxFG[K/R],
where x is from ADEFGLSTVY. Each library therefore contains
a mixture of 2000 phosphopeptides. Each phosphopeptide
library was either fractionated by SCX chromatography or
analyzed directly by LC-MS/MS.
3. Whole-Cell Lysates. Mouse fibroblast NIH 3T3 cells were
cultured at 37 °C, 5% CO2 in Dulbeccos Modified Eagle Medium
(Invitrogen) supplemented with 2 mM L-Glutamine (Invitro-
gen), 0.1 mg/mL streptomycin, 0.2 U/mL penicillin (Sigma) and
10% v/v donor bovine serum (Invitrogen). Following serum
starvation in media containing 0.1% serum for 18 h, cells were
treated with 2 mM sodium pervanadate for 20 min, prior to
lysis. Cells were lysed by sonication in ice-cold urea lysis buffer
(17 mM HEPES pH 8, 7.65 M urea, 1 mM Na3VO4, 50 mM NaF,
25 mM -glycerophosphate and 1 tablet of complete mini
protease inhibitor cocktail (Roche Diagnostics) for every 10 mL
of buffer).The lysates were reduced (8 mM DTT) and alkylated
(20 mM iodoacetamide) in 50 mM ammonium bicarbonate.
The lysates were diluted to 4 M urea, acetonitrile (10% by
volume) and endoproteinase Lys-C were added (Sigma; 1:400
enzyme:protein) and digestion was allowed to proceed at 37
°C for 5 h. The lysates were then further diluted to 1 M urea,
trypsin (Trypsin Gold; Promega, Madison, WI) was added (1:
100 enzyme:protein) prior to overnight digestion at 37 °C.
Peptides were desalted and phosphopeptides were enriched
using TiO2 affinity.18 Bulk enrichment was carried out in an
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Eppendorf-type tube, rather than small columns, however the
rest of the protocol was as previously described.19 Both the
phosphopeptide-enriched eluate and the flow-through (un-
bound fraction) were retained for MS analysis.
Liquid Chromatography Tandem Mass Spectrometry
(LC-MS/MS). CID and ECD Data. Online liquid chromatog-
raphy was performed by use of a Micro AS autosampler and
Surveyor MS pump (Thermo Electron, San Jose, CA). Peptides
were loaded onto a 75 µm (internal diameter) Integrafrit (New
Objective, USA) C8 resolving column (length 10 cm) and
separated over a 40 min gradient from 0% to 40% acetonitrile
(Baker, Holland). Peptides eluted directly (∼350 nL/min) via a
Triversa nanospray source (Advion Biosciences, NY) into a 7 T
Thermo Finnigan LTQ FT mass spectrometer (Thermo Elec-
tron), where they were subjected either to data-dependent CID
or ECD. CID and ECD parameters were approximately as
previously described.19,20
ETD Data. Online liquid chromatography was performed by
use of a Micro AS autosampler and Surveyor MS pump
(Thermo Fisher Scientific, San Jose, CA). Peptides were loaded
onto a C18 trapping column (100 µm internal diameter, 2 cm
length, nanoseparations, The Netherlands) and separated on
a C18 analytical column (75 µm inner diameter, length 10 cm,
nanoseparations, The Netherlands) over a 30 min gradient from
0% to 35% acetonitrile (Fisher Scientific, USA). Peptides eluted
directly (∼300 nL/min) into a LTQ Orbitrap XL ETD mass
spectrometer (Thermo Fisher Scientific, Bremen, Germany).
Electron transfer dissociation was induced in the LTQ and ETD
fragment ions were either detected in the LTQ or in the
Orbitrap mass analyzer.
ETD reaction time was set to 100 msec for all charge states.
Singly charged ions were rejected. Target value settings were 5
× 105 for FT full scans, 1 × 105 for ETD with Orbitrap detection
and 1 × 104 for ETD with LTQ detection.
Data Analysis: OMSSA Database Search Algorithm. DTA
files were created from the raw data using Bioworks 3.3.1
(Thermo Fisher Scientific Inc.). For the whole-cell lysate data,
the OMSSA browser was employed to search the DTA files
against a concatenated database consisting of the mouse IPI
database (Version 3.40) and the reversed-sequence version of
the same database. The synthetic phosphopeptide libraries data
were searched against a concatenated database consisting of
32 400 NCBIDrosophila melanogaster sequences and the library
sequences with either K or R added to the N-terminus (to create
reversed versions of the same mass).
OMSSA settings for the whole-cell lysate high mass accuracy
ETD and ECD searches were as follows. Enzyme: trypsin.
Peptide m/z tolerance: 1.1 (. MS/MS m/z tolerance: 0.02 (.
Mis-cleavage allowed: 2. Fixed modifications: carbamidomethyl
C. Variable modifications: acetylation of protein N-terminus,
oxidation of M, phosphorylation of S, T, Y. Product ion types
to search: c, z, y. E-value cutoff: 50. Allow N-terminal Met
cleavage: yes. Allow elimination of charge-reduced precursors
in spectrum: yes. Precursor charge-state detection: read from
input file data. Alterations to the above settings for the various
searches are detailed below. OMSSA settings for the synthetic
peptide ECD search: Mis-cleavage allowed: 1. Variable modi-
fications: phosphorylation of S, T, Y. OMSSA settings for the
low mass accuracy synthetic peptide CID search: Peptide m/z
tolerance: 0.02 (. MS/MS m/z tolerance: 0.8 (. Product ion
types to search: b,y. OMSSA settings for the low resolution ETD
search: Peptide m/z tolerance: 0.02 (. MS/MS m/z tolerance:
0.8 (.
OMSSA results were filtered to allow only the top scoring
identification (sequence and site of modification) per DTA. The
results were then filtered by precursor mass error (in ppm) and
e-value to obtain a false-discovery rate for phosphopeptides
lower than 2% for each search (FDR ) reverse hits/forward hits
× 100).
SLoMo settings for the various data sets are detailed below.
All searches: tolerance ) 4 (window for removing precursor
and neutral-loss peaks); doubly charged fragment ions were
allowed for triply charged and higher charge-state precursors.
ECD and ETD data: c, z, z-prime and y ions; fragment ion
tolerance of 13 ppm (high resolution) or 400 ppm (low
resolution ETD data). CID data: b, y ions; fragment ion
tolerance of 400 ppm.
Data Analysis: Sequest Database Search Algorithm. Bio-
works (3.3.1) was employed both to generate DTA files from
ECD analysis of mouse whole-cell lysate (flow-through from
the TiO2 enrichment described above) and to carry out a
database search using the Sequest algorithm.21 The database
searched was the mouse IPI database, as described above.
Search parameters were similar to those used above, with the
exception that protein N-terminal acetylation was not available
as a variable modification. The search results were filtered as
above, with the Sequest Xcorr score in place of the OMSSA
e-value. The Trans-Proteomic Pipeline (Seattle Proteome Cen-
ter) was employed to generate a pepXML file. This file was then
used by SLoMo to localize methionine oxidation. SLoMo search
parameters were as described for ECD above.
Results
Algorithm. SLoMo is modeled on the Ascore algorithm,
which is discussed in detail by Beausoleil et al.6 We therefore
present here an overview of the algorithm with particular
attention paid to the areas that have been enhanced.
Assignment of a site localization and its associated score
begins with an analysis of the MS/MS spectrum for the peptide
in question. The mass spectrum is first cleared of all peaks
corresponding to precursor ions, charge-reduced ions, and
neutral loss ions according to the dissociation method being
used, that is, precursor ions and charge-reduced ions for ETD/
ECD and neutral loss ions for CID. The mass spectrum is split
into regions, or windows, of 100m/z width. From each of these
regions the most intense i peaks are selected, where i is an
integer between 1 and 10. For example, a list generated at 5
peaks per window contains the 5 most intense peaks in each
100 m/z window. Once lists of peaks have been determined
for each peak depth, the software then generates a list of all
potential modification sites by examining the peptide sequence
determined from the mass spectrum via a protein database
search algorithm (e.g., Sequest, OMSSA etc.). At this point our
new algorithm deviates from the original. Through use of the
information available in pepXML data files, it is possible to see
all combinations of residues and mass differences considered
by the protein database search algorithm when searching for
modified peptides. These data are read by SLoMo and used to
determine the potential modifications for which it can search.
For OMSSA output, SLoMo parses the file to detect all modi-
fications found. For each modification, the corresponding
UniMod record is found, and the user prompted to select which
amino acid(s) should be considered as possible sites for this
modification. Once this step is complete, SLoMo allows the user
to select from any of the modification types detected to perform
site localization. If there is more than one type of modification
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present in a peptide, the modifications not selected for site
localization are assumed to have been correctly localized by
the protein database search algorithm.
Once a modification type has been selected, all potential
combinations of modification sites within a peptide are cal-
culated, and for each combination a list of hypothetical ions
is generated. SLoMo allows different ion sets to be generated.
In common with Ascore, lists of b and y ions are generated for
CID data. However, SLoMo can also generate any other
combination of ion sets, so that mass spectra containing c, y
and z• ions generated by ECD/ETD, may be searched. The
SLoMo ion generator can produce ion lists for most common
ion types, and those ion types can be combined together in
any way. Likewise searching for multiply charged ions is also
entirely optional and can be turned on or off. An established
feature of ECD and ETD is hydrogen transfer between comple-
mentary fragments, resulting in c• and z′ ions.22 The resulting
z´ ions are commonly observed and can therefore optionally
be used in site localization by SLoMo.
The ion lists generated by SLoMo are matched against the
peak lists (i.e., 1 to 10 peaks per window). In contrast to the
Ascore algorithm, the maximum permitted difference between
Figure 1. Example of SLoMo output: SLoMo output for the phosphopeptide IDISPSYFRK. (A) Preprocessed MS/MS spectrum after
precursor removal and generation of peak-per-window list. Color represents the ranked intensity of peaks within each window (1 )
most intense). (B) Modification scoring output. Each line shows the score for a different site of modification. In this example, the
scores for putative phosphopeptide IDISPSY*FRK at each peak depth are shown in red. The scores for putative phosphopeptide
IDISPS*YFRK are shown in blue and for putative phosphopeptide IDIS*PSYFRK are shown in green. (Note that the algorithm labels
the N-terminal amino acid as “0”, hence phosphopeptide IDIS*PSYFRK is labeled “3” and so on). (C) Comparison of site-determining
ions. In this example, the highest scoring peptides were IDIS*PSYFRK and ISISPS*YFRK. The two lists show all the ions observed
within the MS/MS spectrum at the optimum peak depth, i.e., at which the largest difference in scores is first observed, (defined as 5
in this case). Ions highlighted in red are site-determining. “Diff” indicates mass error (in m/z). (D) (Top) Program output from SLoMo
describing its actions at each stage of the analysis process in addition to the final score for the localization. (Bottom) All possible
site-determining ions for the two highest scoring possibilities in this example.
research articles Bailey et al.
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a hypothetical ion and a peak for a match may be customized,
and is expressed in parts per million (ppm) rather than m/z.
Expressing the fragment ion tolerance in ppm better reflects
the errors in mass measurement in both low and high resolu-
tion data, i.e., ∆ppm is relatively constant across them/z range
of the mass spectrum, while ∆m/z increases with fragmentm/z.
Peptide scores are calculated using a binomial probability
model. This approach however runs into computational prob-
lems as the number of trials increases and, above approxi-
mately 150 trials, it becomes impossible to calculate a score
owing to overflow/underflow problems with the numbers used
to calculate the binomial probability. (Overflow/underflow
errors are caused by the computer trying to work with numbers
which are too big/too small, respectively, for it to handle).
When this situation occurs, SLoMo uses a Poisson model for
calculations, with checks for number overflow or underflow
fail, and an additional check being done to ensure that n × p
and n × p × q are within 10% of each other, i.e., that the
Poisson model is a close approximation to the equivalent
binomial model. As for Ascore, the probabilities are converted
into a log score via the equation:
Score ) -10 × log(P)
As for Ascore, the peptide score for each site-localized
peptide (i.e., peptide in which the modification is assigned to
a specific site) is calculated as a weighted average of the scores
for each peak depth (1 peak per window ) 0.5; 2 ) 0.75; 3 ) 1;
4 ) 1; 5 ) 1; 6 ) 1; 7 ) 0.75; 8 ) 0.5; 9 ) 0.25; 10 ) 0.25). Data
from the two site-localized peptides with the highest peptide
scores are used to generate the final score. At this stage only
site-determining ions are used in the calculation. A site-
determining ion is any ion unique to the site-localized peptide
in question. The list of site-determining ions is compared
against the list of peaks at x peaks per windows, where x is the
lowest number peaks per window for which the difference
between the two peptide scores is maximal. The score is
calculated as described above and the final score is the
difference between the score for the top and second placed
modification sites. An example of the HTML output generated
for each localization is shown in Figure 1.
Testing and Validation. SLoMo was tested against a series
of data sets to ensure (i) it produced accurate site localizations
for data which could also be analyzed by Ascore, and (ii) could
generate accurate localization data for datasets generated by
different dissociation techniques. Both synthetic phosphopep-
tides, with known sites of phosphorylation, and in vivo phos-
phorylated peptides with subsequent manual validation were
used to assess SLoMo site localization.
Comparison with Ascore. In order to compare the output
of SLoMo with that of Ascore, we took a set of 135 phospho-
peptides available on the Ascore Web site, and analyzed them
with both SLoMo and Ascore. From this set of 135, Ascore
successfully (score g 19) localized the site of phosphorylation
in 79 peptides, compared to 75 using an identical score cutoff
for SLoMo. The overlap between successfully localized phos-
phopeptides was approximately 90% (70 cases). For 8 of the 9
peptides which were confidently localized by Ascore but not
by SLoMo, the SLoMo localization agreed but the SLoMo score
was below 19. SLoMo could not distinguish between the top
possibilities for the final peptide.
Within the set of peptides where either method produced
a localization (regardless of score) (n ) 116), a total of six
were localized by SLoMo but not by Ascore, and 4 were
localized by Ascore but not by SLoMo. There were also a
total of three peptides where the site(s) of localization
differed between the two algorithms, however the scores for
these peptides were below 19 in all cases. This experiment
also demonstrated the expected good correlation between
Ascores and SLoMo scores (R2 ) 0.84, see Supplementary
Figure 1, Supporting Information).
Application of SLoMo to ECD and ETD Data. To test the
performance of SLoMo on ECD data, we acquired both CID
and ECD mass spectra from two synthetic phosphopeptide
libraries. Each library consists of a mixture of two thousand
distinct phosphopeptides, with a common peptide backbone.
Each library phosphopeptide has at least two potential sites of
phosphorylation, with a maximum of five potential sites,
depending upon the identity of the variable amino acids. The
actual site of phosphorylation is fixed at serine 7 for both
libraries. The sites assigned by SLoMo are shown in Table 1,
top half. The performance of SLoMo was also tested on a small
number of phosphopeptides enriched frommammalian whole-
cell lysates, with manual validation of the assigned sites. Three
data sets were used in these tests: ECD data and ETD data
acquired with both high and low resolution. The results are
shown in Table 1, bottom half. The error rates are within the
expected ranges, that is <1.3%, 1.3-3.2% and 3.2-10% for
scores of >19, 15-19, and 10-15, respectively.
Influence of Fragment Ion Mass Tolerance on Site Local-
ization by SLoMo. The combined CID synthetic peptide
libraries (Table 1, rows 1 and 2) were searched with varying
Table 1. SLoMo Validation Using Synthetic Phosphopeptide Libraries and Phosphopeptides Enriched from Whole-Cell Lysatesa
number of localized sites (errors and multiple top hits)
data type number of mass spectra score: g19 15-19 10-15 <10
Synthetic peptides (x is from ADEFGLSTVY)
CID GPSGxVpSxAQLx[K/R] 487 353 (0) 67 (0) 40 (2) 27 (23)
CID SxPFKxpSPLxFG[K/R] 420 350 (0) 26 (1) 26 (1) 18 (11)
ECD GPSGxVpSxAQLx[K/R] 202 180 (0) 2 (0) 0 (0) 20 (20)
ECD SxPFKxpSPLxFG[K/R] 406 356 (4) 4 (0) 0 (0) 46 (46)
Whole-cell lysate (manually checked localizations)
ETD (low resolution) WCL phosphopeptides 82 56 (0) 4 (1) 5 (1) 17 (14)
ETD (high resolution) WCL phosphopeptides 54 40 (0) 3 (1) 1 (1) 10 (10)
ECD (high resolution) WCL phosphopeptides 41 29 (0) 3 (1) 1 (1) 7 (7)
a CID and ECD data were acquired with a 7T Thermo Finnigan LTQ-FT mass spectrometer. ETD data was acquired with a Thermo Fisher Orbitrap XL,
using either the Orbitrap (high resolution) or LTQ (low resolution) detector. All the peptides included in the table contained multiple potential
phosphorylation sites. The numbers in brackets indicate the number of errors or disagreements (or multiple top hits, when SLoMo was unable to localise
the modification).
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fragment ion tolerances, from 10 to 5000 ppm. The number of
confident localizations reaches a maximum around the true
mass accuracy of the acquired data (approximately 400 ppm
error; Figure 2). Picking a mass tolerance much larger than
necessary causes the SLoMo scores to drop, while reducing the
mass tolerance to an unrealistically small value causes an
increase in mass spectra with no site assignment (effectively a
score of 0). The error rates were relatively constant, with the
exception of a spike in high-scoring errors when the mass
tolerance was reduced to 10 ppm.
Localization of Methionine Oxidation. To demonstrate the
localization of a modification other than phosphorylation, a
mouse whole-cell lysate sample was analyzed (the flow-through
from the phosphopeptide enrichment described above) and
sites of methionine oxidation were localized. In this case, the
input to SLoMo was a pepXML file generated from a Sequest
database search. An example of the successful localization of
methionine oxidation is shown in Supplementary Figure 2
(Supporting Information).
Conclusion
The results presented here demonstrate that SLoMo is a
suitable tool for localization of sites of modification within
peptides identified by mass spectrometry. In this study, we
demonstrate that phosphorylation can easily be localized using
data obtained from a variety of fragmentation methods, namely
ECD, ETD and CID. The high degree of concordance between
SLoMo and Ascore and the low error rates returned from
synthetic phosphopeptides and manual validation demonstrate
the accuracy of the algorithm. SLoMo has been validated using
both high and low resolution test data generated from two
instruments (LTQ-FT and Orbitrap). We have also demon-
strated the applicability of SLoMo to other modifications using
the example of methionine oxidation, and shown that SLoMo
accepts outputs from a variety of protein database search
engines (OMSSA, Sequest).
SLoMo demonstrates general applicability to problems where
localization of sites of modification is required for peptides
identified in high throughput mass spectrometry experiments.
With SLoMo, researchers now have a tool which is capable of
undertaking site determination analysis for a range of different
modifications examined using multiple dissociation techniques.
User-defined ppm mass tolerances allow SLoMo to be applied
to data generated from different instruments (e.g., ion-trap,
QToF and FT-ICR) and the generic pepXML input format makes
SLoMo compatible with multiple database search algorithms.
The program is extensible and modifiable: end users can easily
customize the parameters used to search for localizations.
Similarly, adapting the program to accommodate any new
dissociation technique which may become available is straight-
forward. SLoMo is available for download for multiple platforms
from http://massspec.bham.ac.uk/slomo.
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Figure 2. Influence of fragment mass tolerance on SLoMo localization of phosphorylation. The combined CID mass spectra (n ) 907)
of the synthetic phosphopeptide libraries were searched using different fragment mass tolerances. The number of errors >19 ranged
from 11 to 0 and is shown multiplied 10-fold.
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Figure 1. Comparison of Ascore scores and SLoMo scores. Score
output for 135 phosphopeptides examined using Ascore (x-axis)
and SLoMo (y-axis).Supplementary Figure 2. SLoMo output
showing successful localization of methionine oxidation. This
material is available free of charge via the Internet at http://
pubs.acs.org.
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